QuantaLife Wins $820K from NIH to Develop MRSA Test for Digital PCR Platform
August 26, 2010
QuantaLife Wins $820K from NIH to Develop MRSA Test for Digital PCR Platform
QuantaLife has been awarded $820,000 in the first year of a five-year project with the University of Mississippi Medical Center to develop microdroplet PCR-based point-of-care tests to detect methicillin-resistant Staphylococcus aureus.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Digital PCR Sales Contribute to Record Q4 Revenues for Bio-Rad's Life Sciences Segment
February 28, 2013 / PCR Insider - Bio-Rad Doubles Q3 Digital PCR Sales Over Q2; Execs Project Strong Uptake in Future Quarters
November 8, 2012 / PCR Insider - Study Finds Digital PCR No Better than Real-Time PCR for Low-Level HIV Detection, Quantification
October 11, 2012 / PCR Insider - Harvard Group Using Bio-Rad Digital PCR System as Part of NHGRI-Funded Study of Multi-Allelic CNV
August 23, 2012 / PCR Insider - Bio-Rad Life Sciences Q2 Revenues Drop 4 Percent; Digital PCR Sales Slower than Anticipated
August 9, 2012 / PCR Insider